The hydrolytic processing of metallic bismuth with the production of bismuth oxohydroxotribromophenolate pharmacopeial composition [Bi6O6(OH)2](C6H2Br3O)4 used to prepare the medical drug Xeroform was studied by chemical, X-ray diffraction, and thermogravimetric analyses and electron microscopy. The results of these studies were confirmed by the industrial tests of the developed technology based on the oxidation of metallic bismuth, the dissolution of synthesized technical oxide in nitric acid, the hydrolytic purification of bismuth from impurity metals by aqueous alkaline hydrolysis with the precipitation of bismuth in the form of oxohydroxonitrate [Bi6O4(OH)4](NO3)6?H2O, the dissolution of bismuth oxohydroxonitrate in nitric acid, and the synthesis of bismuth oxohydroxotribromophenolate by adding an aqueous sodium tribromophenolate solution to the resulting solution in the presence of sodium acetate at a pH of 6.5–7.5 and a temperature of 90–95°C.
相似文献